SE520811C2 - Hudskyddspreparat innehållande lipofila och hydrofila komponenter, förfarande för framställning och användning därav - Google Patents

Hudskyddspreparat innehållande lipofila och hydrofila komponenter, förfarande för framställning och användning därav

Info

Publication number: SE520811C2
Authority: SE; Sweden
Prior art keywords: skin; skin protection; protection composition; mixture; composition according
Prior art date: 1997-01-17

Application number

SE9700129A

Other languages

English (en)

Swedish (sv)

Other versions

SE9700129L (sv

SE9700129D0 (sv

Inventor

Goeran Freij

Original Assignee

Ponsus Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-17

Filing date

1997-01-17

Publication date

2003-08-26

1997-01-17 Application filed by Ponsus Ab filed Critical Ponsus Ab

1997-01-17 Priority to SE9700129A priority Critical patent/SE520811C2/sv

1997-01-17 Publication of SE9700129D0 publication Critical patent/SE9700129D0/xx

1998-01-12 Priority to JP10037891A priority patent/JP3006572B2/ja

1998-01-15 Priority to PT98901623T priority patent/PT961610E/pt

1998-01-15 Priority to EP98901623A priority patent/EP0961610B1/de

1998-01-15 Priority to AU57861/98A priority patent/AU744980C/en

1998-01-15 Priority to DE69827929T priority patent/DE69827929T2/de

1998-01-15 Priority to ES98901623T priority patent/ES2234091T3/es

1998-01-15 Priority to RU99117924/14A priority patent/RU2196566C2/ru

1998-01-15 Priority to CN98801871A priority patent/CN1243431A/zh

1998-01-15 Priority to BRPI9806774-5A priority patent/BR9806774B1/pt

1998-01-15 Priority to DK98901623T priority patent/DK0961610T3/da

1998-01-15 Priority to PCT/SE1998/000054 priority patent/WO1998031339A1/en

1998-01-15 Priority to CA002278521A priority patent/CA2278521C/en

1998-01-15 Priority to AT98901623T priority patent/ATE283684T1/de

1998-01-16 Priority to US09/008,632 priority patent/US5993830A/en

1998-07-18 Publication of SE9700129L publication Critical patent/SE9700129L/xx

1999-06-28 Priority to NO19993201A priority patent/NO313314B1/no

2003-08-26 Publication of SE520811C2 publication Critical patent/SE520811C2/sv

Links

238000002360 preparation method Methods 0.000 title claims abstract description 35
238000000034 method Methods 0.000 title claims abstract description 24
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
239000012528 membrane Substances 0.000 claims abstract description 11
230000008569 process Effects 0.000 claims abstract description 10
238000004519 manufacturing process Methods 0.000 claims abstract description 4
239000000203 mixture Substances 0.000 claims description 121
235000014113 dietary fatty acids Nutrition 0.000 claims description 43
239000000194 fatty acid Substances 0.000 claims description 43
229930195729 fatty acid Natural products 0.000 claims description 43
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 39
150000004665 fatty acids Chemical class 0.000 claims description 38
229910052799 carbon Inorganic materials 0.000 claims description 25
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 20
GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 19
239000004205 dimethyl polysiloxane Substances 0.000 claims description 14
235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 14
229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 14
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 13
229920001223 polyethylene glycol Polymers 0.000 claims description 13
229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 13
235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 13
239000000600 sorbitol Substances 0.000 claims description 13
239000002202 Polyethylene glycol Substances 0.000 claims description 12
239000001267 polyvinylpyrrolidone Substances 0.000 claims description 12
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 11
239000000126 substance Substances 0.000 claims description 11
238000013019 agitation Methods 0.000 claims description 10
150000001721 carbon Chemical group 0.000 claims description 10
125000004432 carbon atom Chemical group C* 0.000 claims description 10
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 9
239000006260 foam Substances 0.000 claims description 9
239000000686 essence Substances 0.000 claims description 7
239000003205 fragrance Substances 0.000 claims description 7
239000003755 preservative agent Substances 0.000 claims description 7
-1 carbon fatty acid Chemical class 0.000 claims description 6
239000004088 foaming agent Substances 0.000 claims description 6
239000003814 drug Substances 0.000 claims description 5
206010040880 Skin irritation Diseases 0.000 claims description 4
230000002335 preservative effect Effects 0.000 claims description 4
230000036556 skin irritation Effects 0.000 claims description 4
231100000475 skin irritation Toxicity 0.000 claims description 4
230000035484 reaction time Effects 0.000 claims description 3
239000013543 active substance Substances 0.000 claims description 2
239000000443 aerosol Substances 0.000 claims description 2
ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 claims 1
210000003491 skin Anatomy 0.000 description 110
238000002474 experimental method Methods 0.000 description 36
230000000694 effects Effects 0.000 description 20
238000012360 testing method Methods 0.000 description 17
230000006872 improvement Effects 0.000 description 10
241000699670 Mus sp. Species 0.000 description 9
208000015181 infectious disease Diseases 0.000 description 8
230000003204 osmotic effect Effects 0.000 description 8
201000004624 Dermatitis Diseases 0.000 description 7
230000001681 protective effect Effects 0.000 description 7
208000024891 symptom Diseases 0.000 description 7
241001465754 Metazoa Species 0.000 description 6
239000006071 cream Substances 0.000 description 6
206010020751 Hypersensitivity Diseases 0.000 description 5
208000003251 Pruritus Diseases 0.000 description 5
239000002253 acid Substances 0.000 description 5
230000007815 allergy Effects 0.000 description 5
230000004888 barrier function Effects 0.000 description 5
230000007803 itching Effects 0.000 description 5
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
241001148106 Brucella melitensis Species 0.000 description 4
206010006500 Brucellosis Diseases 0.000 description 4
206010070834 Sensitisation Diseases 0.000 description 4
208000026935 allergic disease Diseases 0.000 description 4
208000010668 atopic eczema Diseases 0.000 description 4
229940038698 brucella melitensis Drugs 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
229940079593 drug Drugs 0.000 description 4
IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
229920003023 plastic Polymers 0.000 description 4
239000004033 plastic Substances 0.000 description 4
230000008313 sensitization Effects 0.000 description 4
239000002884 skin cream Substances 0.000 description 4
230000037394 skin elasticity Effects 0.000 description 4
239000007787 solid Substances 0.000 description 4
241000589562 Brucella Species 0.000 description 3
206010030012 Occupational dermatitis Diseases 0.000 description 3
206010040844 Skin exfoliation Diseases 0.000 description 3
208000028990 Skin injury Diseases 0.000 description 3
206010070835 Skin sensitisation Diseases 0.000 description 3
239000013566 allergen Substances 0.000 description 3
229920001971 elastomer Polymers 0.000 description 3
239000000839 emulsion Substances 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
239000002085 irritant Substances 0.000 description 3
231100000021 irritant Toxicity 0.000 description 3
231100000370 skin sensitisation Toxicity 0.000 description 3
241000700198 Cavia Species 0.000 description 2
206010012442 Dermatitis contact Diseases 0.000 description 2
206010015150 Erythema Diseases 0.000 description 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
201000009053 Neurodermatitis Diseases 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
235000021314 Palmitic acid Nutrition 0.000 description 2
206010040914 Skin reaction Diseases 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
230000008901 benefit Effects 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
208000010247 contact dermatitis Diseases 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000035618 desquamation Effects 0.000 description 2
229940008099 dimethicone Drugs 0.000 description 2
235000021588 free fatty acids Nutrition 0.000 description 2
230000009610 hypersensitivity Effects 0.000 description 2
230000006698 induction Effects 0.000 description 2
238000011081 inoculation Methods 0.000 description 2
230000002147 killing effect Effects 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
230000000306 recurrent effect Effects 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
231100001068 severe skin irritation Toxicity 0.000 description 2
230000035483 skin reaction Effects 0.000 description 2
231100000430 skin reaction Toxicity 0.000 description 2
210000000952 spleen Anatomy 0.000 description 2
210000000434 stratum corneum Anatomy 0.000 description 2
230000035900 sweating Effects 0.000 description 2
TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
229920000742 Cotton Polymers 0.000 description 1
101100202529 Danio rerio scoca gene Proteins 0.000 description 1
235000009161 Espostoa lanata Nutrition 0.000 description 1
240000001624 Espostoa lanata Species 0.000 description 1
208000004262 Food Hypersensitivity Diseases 0.000 description 1
206010016946 Food allergy Diseases 0.000 description 1
101000713575 Homo sapiens Tubulin beta-3 chain Proteins 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
238000011887 Necropsy Methods 0.000 description 1
229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
241000863032 Trieres Species 0.000 description 1
102100036790 Tubulin beta-3 chain Human genes 0.000 description 1
230000009471 action Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000007059 acute toxicity Effects 0.000 description 1
231100000403 acute toxicity Toxicity 0.000 description 1
239000000654 additive Substances 0.000 description 1
229940035674 anesthetics Drugs 0.000 description 1
238000010171 animal model Methods 0.000 description 1
125000004429 atom Chemical group 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000003518 caustics Substances 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
230000007797 corrosion Effects 0.000 description 1
238000005260 corrosion Methods 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
230000008021 deposition Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
230000002497 edematous effect Effects 0.000 description 1
238000005265 energy consumption Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
238000004299 exfoliation Methods 0.000 description 1
235000020932 food allergy Nutrition 0.000 description 1
230000006870 function Effects 0.000 description 1
239000000417 fungicide Substances 0.000 description 1
239000003193 general anesthetic agent Substances 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
238000011534 incubation Methods 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
230000003902 lesion Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000037368 penetrate the skin Effects 0.000 description 1
239000000575 pesticide Substances 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
229940068977 polysorbate 20 Drugs 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
230000009993 protective function Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000000630 rising effect Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
230000037380 skin damage Effects 0.000 description 1
239000000344 soap Substances 0.000 description 1
WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
230000000475 sunscreen effect Effects 0.000 description 1
239000000516 sunscreening agent Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000006264 topical foam Substances 0.000 description 1
229940042130 topical foam Drugs 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Birds (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Toxicology (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)
Saccharide Compounds (AREA)
Laminated Bodies (AREA)
Bakery Products And Manufacturing Methods Therefor (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

SE9700129A 1997-01-17 1997-01-17 Hudskyddspreparat innehållande lipofila och hydrofila komponenter, förfarande för framställning och användning därav SE520811C2 (sv)

Priority Applications (16)

Application Number	Priority Date	Filing Date	Title
SE9700129A SE520811C2 (sv)	1997-01-17	1997-01-17	Hudskyddspreparat innehållande lipofila och hydrofila komponenter, förfarande för framställning och användning därav
JP10037891A JP3006572B2 (ja)	1997-01-17	1998-01-12	皮膚製剤
AT98901623T ATE283684T1 (de)	1997-01-17	1998-01-15	Hautpflegemittel
CN98801871A CN1243431A (zh)	1997-01-17	1998-01-15	皮肤制剂
BRPI9806774-5A BR9806774B1 (pt)	1997-01-17	1998-01-15	preparado para pele.
AU57861/98A AU744980C (en)	1997-01-17	1998-01-15	Skin preparation
DE69827929T DE69827929T2 (de)	1997-01-17	1998-01-15	Hautpflegemittel
ES98901623T ES2234091T3 (es)	1997-01-17	1998-01-15	Preparacion para la piel.
RU99117924/14A RU2196566C2 (ru)	1997-01-17	1998-01-15	Композиция для кожи
PT98901623T PT961610E (pt)	1997-01-17	1998-01-15	Preparacao para a pele
EP98901623A EP0961610B1 (de)	1997-01-17	1998-01-15	Hautpflegemittel
DK98901623T DK0961610T3 (da)	1997-01-17	1998-01-15	Hudpræparat
PCT/SE1998/000054 WO1998031339A1 (en)	1997-01-17	1998-01-15	Skin preparation
CA002278521A CA2278521C (en)	1997-01-17	1998-01-15	Two phase skin preparations comprising lipophilic and hydrophilic components
US09/008,632 US5993830A (en)	1997-01-17	1998-01-16	Cosmetic skin preparation
NO19993201A NO313314B1 (no)	1997-01-17	1999-06-28	Hudpreparat, fremgangsmåte for fremstilling og anvendelse derav

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9700129A SE520811C2 (sv)	1997-01-17	1997-01-17	Hudskyddspreparat innehållande lipofila och hydrofila komponenter, förfarande för framställning och användning därav

Publications (3)

Publication Number	Publication Date
SE9700129D0 SE9700129D0 (sv)	1997-01-17
SE9700129L SE9700129L (sv)	1998-07-18
SE520811C2 true SE520811C2 (sv)	2003-08-26

Family

ID=20405448

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9700129A SE520811C2 (sv)	1997-01-17	1997-01-17	Hudskyddspreparat innehållande lipofila och hydrofila komponenter, förfarande för framställning och användning därav

Country Status (15)

Country	Link
US (1)	US5993830A (de)
EP (1)	EP0961610B1 (de)
JP (1)	JP3006572B2 (de)
CN (1)	CN1243431A (de)
AT (1)	ATE283684T1 (de)
AU (1)	AU744980C (de)
BR (1)	BR9806774B1 (de)
CA (1)	CA2278521C (de)
DE (1)	DE69827929T2 (de)
ES (1)	ES2234091T3 (de)
NO (1)	NO313314B1 (de)
PT (1)	PT961610E (de)
RU (1)	RU2196566C2 (de)
SE (1)	SE520811C2 (de)
WO (1)	WO1998031339A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6649174B2 (en) *	1998-05-07	2003-11-18	E-L Management Corp.	Dual phase cosmetic composition
JP2001240533A (ja)	2000-02-29	2001-09-04	Kao Corp	経皮投与型製剤
SE0104421D0 (sv)	2001-12-21	2001-12-21	Ponsus Pharma Ab	New composition
AU2003233396B2 (en) *	2002-03-13	2007-05-24	Thomas Skold	Water-based delivery systems
US20050129722A1 (en) *	2002-03-13	2005-06-16	Collagenex Pharmaceuticals, Inc.	Water-based delivery systems
IL152486A0 (en)	2002-10-25	2003-05-29	Meir Eini	Alcohol-free cosmetic and pharmaceutical foam carrier
US20080138296A1 (en)	2002-10-25	2008-06-12	Foamix Ltd.	Foam prepared from nanoemulsions and uses
US9668972B2 (en)	2002-10-25	2017-06-06	Foamix Pharmaceuticals Ltd.	Nonsteroidal immunomodulating kit and composition and uses thereof
US7700076B2 (en)	2002-10-25	2010-04-20	Foamix, Ltd.	Penetrating pharmaceutical foam
US9265725B2 (en)	2002-10-25	2016-02-23	Foamix Pharmaceuticals Ltd.	Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en)	2002-10-25	2018-11-06	Foamix Pharmaceuticals Ltd.	Foamable composition combining a polar solvent and a hydrophobic carrier
ES2532906T5 (es) †	2002-10-25	2022-03-23	Foamix Pharmaceuticals Ltd	Espuma cosmética y farmacéutica
US7704518B2 (en)	2003-08-04	2010-04-27	Foamix, Ltd.	Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en)	2002-11-29	2015-12-15	Foamix Pharmaceuticals Ltd.	Antibiotic kit and composition and uses thereof
EA009660B1 (ru) *	2002-12-12	2008-02-28	Нойбург Скин Кэа Гмбх & Ко. Кг	Стабильный пенистый крем для ухода за кожей
ITMI20030343A1 (it) *	2003-02-26	2004-08-27	Biofarm S R L Ora Biofarmitalia S P A	Gel cosmetico o curativo applicabile sulla pelle umana.
RU2322992C2 (ru) *	2006-05-22	2008-04-27	Государственное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей Федерального агентства по здравоохранению и социальному развитию"	Средство для профилактики контактных аллергических дерматозов, вызываемых солями никеля
WO2008008397A2 (en) *	2006-07-14	2008-01-17	Stiefel Research Australia Pty Ltd	Fatty acid pharmaceutical foam
US20080260655A1 (en)	2006-11-14	2008-10-23	Dov Tamarkin	Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
WO2008089413A2 (en) *	2007-01-19	2008-07-24	Quinnova Pharmaceuticals, Inc.	Urea foam
US8636982B2 (en)	2007-08-07	2014-01-28	Foamix Ltd.	Wax foamable vehicle and pharmaceutical compositions thereof
WO2009032907A2 (en) *	2007-09-04	2009-03-12	Quinnova Pharmaceuticals, Inc.	Stay-on selenium foam
US9439857B2 (en)	2007-11-30	2016-09-13	Foamix Pharmaceuticals Ltd.	Foam containing benzoyl peroxide
WO2009072007A2 (en)	2007-12-07	2009-06-11	Foamix Ltd.	Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
EP2355796A4 (de) *	2008-10-15	2012-04-25	Quinnova Pharmaceuticals Inc	Salicylsäurezusammensetzung
WO2010125470A2 (en)	2009-04-28	2010-11-04	Foamix Ltd.	Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011064631A1 (en)	2009-10-02	2011-06-03	Foamix Ltd.	Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en)	2009-10-02	2017-12-26	Foamix Pharmaceuticals Ltd.	Methods for accelerated return of skin integrity and for the treatment of impetigo
US8409628B2 (en) *	2010-02-04	2013-04-02	Penguin IP Holdings, Inc.	Methods and compositions for oxygenation of skin to treat skin disorders
US9345720B2 (en)	2010-10-26	2016-05-24	Exeltis Usa Dermatology, Inc.	Composition and method for treating wounds
US10543172B2 (en) *	2010-10-26	2020-01-28	Paragon Nordic Ab	Econazole composition and methods of treatment therewith
DE102011018924A1 (de)	2011-04-28	2012-10-31	Tunap Industrie Chemie Gmbh & Co. Produktions Kg	OW-Emulsionskonzentrat, Verfahren zu dessen Herstellung und dieses enthaltendes Hautkosmetikum
US8893443B2 (en) *	2012-02-07	2014-11-25	Tait Towers Manufacturing, LLC	Support structure with stowed implement bracket
US10406088B2 (en)	2015-01-20	2019-09-10	TetraDerm Group LLC	Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration
CN107427472B (zh) *	2015-03-02	2021-04-30	久光制药株式会社	贴附剂
US10398641B2 (en)	2016-09-08	2019-09-03	Foamix Pharmaceuticals Ltd.	Compositions and methods for treating rosacea and acne
US10869818B2 (en)	2017-11-10	2020-12-22	Paragon Nordic Ab	Foamable skin composition
CN114452228B (zh) *	2022-04-14	2022-06-21	新基元(北京)医药科技有限公司	一种用于洗发的二硫化硒泡沫剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3298919A (en) *	1962-12-26	1967-01-17	Dow Corning	Shaving cream containing polysiloxanes
CA1163561A (en) *	1979-11-06	1984-03-13	Cyril Boroda	Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
GB2069333A (en) *	1980-02-19	1981-08-26	Hasbro Industries Inc	Cosmetic composition
US4654208A (en) *	1983-03-01	1987-03-31	Stockel Richard F	Anti-microbial compositions comprising an aqueous solution of a germicidal polymeric nitrogen compound and a potentiating oxidizing agent
US4857328A (en) *	1986-09-29	1989-08-15	Tecma Laboratories, Inc.	Skin therapeutic mixture containing aloe vera extract
US4900550A (en) *	1987-08-19	1990-02-13	Amy Allene Cosmetiques, Inc.	Skin care cosmetic regime
US5008100A (en) *	1989-08-11	1991-04-16	Elizabeth Arden Co., Division Of Conopco, Inc.	Oil-in-water emulsions containing polyethylene
AU8305391A (en) *	1990-10-18	1992-05-20	Isp Investments Inc.	Swellable, crosslinked polyvinylpyrrolidone and cosmetic compositions therewith
RU2021803C1 (ru) *	1991-01-11	1994-10-30	Государственная научно-производственная фирма "Алата"	Крем для кожи рук
US5208013A (en) *	1991-06-03	1993-05-04	Olympus International, Inc.	Composition for skin care and protection
FR2722403B1 (fr) *	1994-07-15	1996-09-20	Biolog Vegetable Yves Rocher L	Composition cosmetique pour la constitution de batons pour les levres ou la peau et leurs procedes de preparation
IL110380A0 (en) *	1994-07-20	1994-10-21	Agis Ind 1983 Ltd	Antiviral topical pharmaceutical compositions
RU2054927C1 (ru) *	1995-03-31	1996-02-27	Научно-производственная фирма "ПАНЭКС"	Крем для ухода за кожей
FR2737117B1 (fr) *	1995-07-25	1997-09-05	Oreal	Composition sous forme de pate souple obtenue par extrusion et procede de preparation

1997
- 1997-01-17 SE SE9700129A patent/SE520811C2/sv not_active IP Right Cessation
1998
- 1998-01-12 JP JP10037891A patent/JP3006572B2/ja not_active Expired - Fee Related
- 1998-01-15 AT AT98901623T patent/ATE283684T1/de active
- 1998-01-15 RU RU99117924/14A patent/RU2196566C2/ru not_active IP Right Cessation
- 1998-01-15 BR BRPI9806774-5A patent/BR9806774B1/pt not_active IP Right Cessation
- 1998-01-15 CA CA002278521A patent/CA2278521C/en not_active Expired - Lifetime
- 1998-01-15 PT PT98901623T patent/PT961610E/pt unknown
- 1998-01-15 EP EP98901623A patent/EP0961610B1/de not_active Expired - Lifetime
- 1998-01-15 ES ES98901623T patent/ES2234091T3/es not_active Expired - Lifetime
- 1998-01-15 WO PCT/SE1998/000054 patent/WO1998031339A1/en not_active Ceased
- 1998-01-15 AU AU57861/98A patent/AU744980C/en not_active Ceased
- 1998-01-15 DE DE69827929T patent/DE69827929T2/de not_active Expired - Lifetime
- 1998-01-15 CN CN98801871A patent/CN1243431A/zh active Pending
- 1998-01-16 US US09/008,632 patent/US5993830A/en not_active Expired - Lifetime
1999
- 1999-06-28 NO NO19993201A patent/NO313314B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0961610B1 (de)	2004-12-01
SE9700129L (sv)	1998-07-18
WO1998031339A1 (en)	1998-07-23
JPH10226637A (ja)	1998-08-25
AU744980B2 (en)	2002-03-07
AU5786198A (en)	1998-08-07
DE69827929D1 (de)	2005-01-05
NO313314B1 (no)	2002-09-16
BR9806774B1 (pt)	2012-09-04
ES2234091T3 (es)	2005-06-16
AU744980C (en)	2003-04-17
CN1243431A (zh)	2000-02-02
EP0961610A1 (de)	1999-12-08
ATE283684T1 (de)	2004-12-15
RU2196566C2 (ru)	2003-01-20
CA2278521C (en)	2005-12-13
NO993201D0 (no)	1999-06-28
CA2278521A1 (en)	1998-07-23
PT961610E (pt)	2005-04-29
SE9700129D0 (sv)	1997-01-17
US5993830A (en)	1999-11-30
DE69827929T2 (de)	2005-11-24
NO993201L (no)	1999-08-26
BR9806774A (pt)	2000-05-16
JP3006572B2 (ja)	2000-02-07

Legal Events

Date	Code	Title	Description
2005-08-30	NUG	Patent has lapsed

Publication	Publication Date	Title
SE520811C2 (sv)	2003-08-26	Hudskyddspreparat innehållande lipofila och hydrofila komponenter, förfarande för framställning och användning därav
US7858570B2 (en)	2010-12-28	Compositions and methods for removing urushiol and treating the resulting skin condition
US10869819B2 (en)	2020-12-22	Compositions having a plurality of discrete emulsions
TW200820989A (en)	2008-05-16	Toner and skin cleanser
US10660866B2 (en)	2020-05-26	Retinol oil composition
JP2009149626A (ja)	2009-07-09	皮膚バリア機能改善剤、及びそれを利用した外用剤組成物
CS224620B2 (en)	1984-01-16	Cosmetic agent and method of producing thereof
JP6062538B2 (ja)	2017-01-18	輝きをもたらす組成物及び使用方法
CN104587279B (zh)	2018-05-04	水包油型薄荷膏及其制备方法
WO2004105689A2 (en)	2004-12-09	Topical composition for the treatment of skin disorders and methods of using the same
CN117257695B (zh)	2025-10-17	发酵水油双层组合物及其制备方法与应用
JPS61263910A (ja)	1986-11-21	頭髪化粧料
JP3479048B2 (ja)	2003-12-15	化粧料及び不織布含浸化粧料
JPS61238716A (ja)	1986-10-24	頭髪化粧料
US11975084B2 (en)	2024-05-07	Composition for application to a surface of skin of a user
CN110496065A (zh)	2019-11-26	补水组合物
RU2786973C1 (ru)	2022-12-26	Антибактериальное средство для обработки рук
US12544361B2 (en)	2026-02-10	Composition comprising at least one oxazoline for inhibiting the growth of Malassezia yeasts involved in cradle cap, in particular
KR102038366B1 (ko)	2019-10-30	여드름 피부 개선용 화장료 조성물
WO1996039118A1 (fr)	1996-12-12	Compositions cosmetiques amincissantes
Twinn et al.	1943	THE CONTROL OF PEDICULOSIS AND SCABIES BY MEANS OF PREPARATIONS CONTAINING PYRETHRINS, ROTENONE, AND ALIPHATIC THIOCYANATES
WO2006107184A1 (en)	2006-10-12	A pharmaceutical composition for the treatment of atopic dermatitis containing 4-hydroxy-5-methoxy-4-[2-methyl-3-(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro [2,5]octan-6-one
JPH0723296B2 (ja)	1995-03-15	皮膚化粧料
JPH11269023A (ja)	1999-10-05	外用組成物
Yadav et al.	0	Formulation and Ev Mathematical Treattm